Table 1 Demographic and laboratory data of AxSpa patients compared with the control group

Age (years)

40 ± 10

37 ± 11

0.49

Male/Female

33/28

15/15

0.65

BMI (kg/m²)

24.9 ± 3

24.2 ± 3

0.53

Treatment

• cDMARD

• TNFi

• NSAID

25%

70.5%

98%

N/A

N/A

N/A

-

ESR (mm/hr)

18 [8–34]

6 [5–15]

< 0.01

CRP (mg/L)

2 [2–9]

2 [2–2]

< 0.01

HLA-B27 Positivity

78.7%

N/A

-

Subfatin (ng/mL)

0.68 [0.4-1]

0.75 [0.5–1.2]

0.40

CTHRC1 (ng/mL)

55 [40–103]

66 [44–128]

0.35

CTRP3 (ng/mL)

1.9 [1.7–2.2]

2.1 [1.7–2.8]

0.09

CTRP6 (ng/mL)

2 [1.3–2.9]

2.3 [1.3–6.1]

0.47

IL-6 (pg/mL)

71 [55–87]

78 [62–129]

0.15

IL-17 (pg/mL)

21 [16–36]

30 [20–58]

0.19

TNF-α (pg/mL)

98 [83–142]

108 [80–152]

0.97